Literature DB >> 26792232

DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder.

Lotte C Houtepen1, Annet H van Bergen1, Christiaan H Vinkers1, Marco P M Boks1.   

Abstract

AIM: In view of the potential effects of psychiatric drugs on DNA methylation, we investigated whether medication use in bipolar disorder is associated with DNA methylation signatures. EXPERIMENTAL PROCEDURES: Blood-based DNA methylation patterns of six frequently used psychotropic drugs (lithium, quetiapine, olanzapine, lamotrigine, carbamazepine, and valproic acid) were examined in 172 bipolar disorder patients. After adjustment for cell type composition, we investigated gene networks, principal components, hypothesis-driven genes and epigenome-wide individual loci.
RESULTS: Valproic acid and quetiapine were significantly associated with altered methylation signatures after adjustment for drug-related changes on celltype composition.
CONCLUSION: Psychiatric drugs influence DNA methylation patterns over and above cell type composition in bipolar disorder. Drug-related changes in DNA methylation are therefore not only an important confounder in psychiatric epigenetics but may also inform on the biological mechanisms underlying drug efficacy.

Entities:  

Keywords:  DNA methylation; antidepressant; antipsychotics; bipolar; cell type; medication; mood stabilizer

Mesh:

Substances:

Year:  2016        PMID: 26792232     DOI: 10.2217/epi.15.98

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  27 in total

1.  Non-genetic transgenerational transmission of bipolar disorder: targeting DNA methyltransferases.

Authors:  G R Fries; C Walss-Bass; J C Soares; J Quevedo
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

Review 2.  The role of DNA methylation in the pathophysiology and treatment of bipolar disorder.

Authors:  Gabriel R Fries; Qiongzhen Li; Blake McAlpin; Theo Rein; Consuelo Walss-Bass; Jair C Soares; Joao Quevedo
Journal:  Neurosci Biobehav Rev       Date:  2016-06-18       Impact factor: 8.989

3.  Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review.

Authors:  Kyle J Burghardt; Audrey S Khoury; Zaher Msallaty; Zhengping Yi; Berhane Seyoum
Journal:  Pharmacotherapy       Date:  2020-03-09       Impact factor: 4.705

Review 4.  Challenges in Analyzing Functional Epigenetic Data in Perspective of Adolescent Psychiatric Health.

Authors:  Diana M Manu; Jessica Mwinyi; Helgi B Schiöth
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

5.  Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance.

Authors:  Kyle J Burghardt; Jacyln M Goodrich; Dana C Dolinoy; Vicki L Ellingrod
Journal:  Bipolar Disord       Date:  2016-08-20       Impact factor: 6.744

6.  MeCP2 Expression in a Rat Model of Risky Decision Making.

Authors:  Jay V Deng; Caitlin A Orsini; Kristy G Shimp; Barry Setlow
Journal:  Neuroscience       Date:  2017-11-16       Impact factor: 3.590

Review 7.  Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.

Authors:  Sarra G Bahna; Lennard P Niles
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

8.  Hypomethylation of FAM63B in bipolar disorder patients.

Authors:  Anna Starnawska; Ditte Demontis; Andrew McQuillin; Niamh L O'Brien; Nicklas H Staunstrup; Ole Mors; Anders L Nielsen; Anders D Børglum; Mette Nyegaard
Journal:  Clin Epigenetics       Date:  2016-05-11       Impact factor: 6.551

9.  CACNA1C hypermethylation is associated with bipolar disorder.

Authors:  A Starnawska; D Demontis; A Pen; A Hedemand; A L Nielsen; N H Staunstrup; J Grove; T D Als; A Jarram; N L O'Brien; O Mors; A McQuillin; A D Børglum; M Nyegaard
Journal:  Transl Psychiatry       Date:  2016-06-07       Impact factor: 6.222

10.  Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis.

Authors:  Rebecca N S Harrison; Robin M Murray; Sang Hyuck Lee; Jose Paya Cano; David Dempster; Charles J Curtis; Danai Dima; Fiona Gaughran; Gerome Breen; Simone de Jong
Journal:  Psychiatr Genet       Date:  2016-10       Impact factor: 2.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.